Aberrant methylation of the 16q23.1 tumor suppressor gene ADAMTS18 promotes tumorigenesis and progression of clear cell renal cell carcinoma
Authors (first, second and last of 4)

Genes & Genomics is the official journal of the Korean Genetics Society (http://kgenetics.or.kr/) since 1978. Although it is an official publication of the Genetics Society of Korea, membership of the Society is not required for contributors. It is a peer-reviewed online only international journal (E-ISSN 2092-9293) publishing 12 issues per year. It covers all disciplines of genetics and genomics, from prokaryotes to eukaryotes, and from fundamental heredity to molecular aspects. The journal publishes reviews, research articles, and short communications.
The journal does not exclude the topics of plant biology, development biology, immunology, cancer, and disease biology if the experimental setup and/or the subsequent analyses are relevant to an audience with a clear interest in genetics and genomics. All content is available through link.springer.com/journal/13258.
The Genetics Society of Korea (GSK) was founded in 1979 to promote the field of genetics and to advance our understanding of genetics at all levels. For this purpose, we foster excellence in research and education in genetics. Most importantly, we provide a communication hub for the scientists in all genetic disciplines. The GSK publishes an international journal Genes & Genomics bimonthly. We organize annual meeting in conjunction with the Korean Association of Biological Sciences (KASB) and symposia, and encourage researchers by means of academic awards. Besides of the scientific and academic activities, we also provide relevant genetic issues to the public by publishing a series of monographic publications.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.